Momenta Pharmaceuticals
Biotechnology company that pioneered the development of complex biosimilars and novel therapeutics for autoimmune and rare diseases. Acquired by Johnson & Johnson in 2020 for $6.5 billion.
Location
Cambridge, Massachusetts, USA
Founded
2001
Investors
1
Categories
biotech, biosimilars, therapeutics, autoimmune, rare-disease, immunology
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Polaris Partners | US | biotech-focused | - | 33 |